Advertisement

Related Videos

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Peter Clark, MA, MD, FRCP: A Payer Perspective

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Advertisement

Advertisement




May
13
Today In Oncology
Global Review Shows Impact of Exposure to Air Pollution on Cancer Risk and Mortality
Addition of Toripalimab to Perioperative Chemotherapy in Locally Advanced Gastric or Gastroesophageal Junction Cancer
Inherited Long Telomeres May Increase the Risk of Lymphoid Cancers
Neoadjuvant Single-Cycle Pembrolizumab for Stage I to III dMMR Colon Cancer
Inflammatory Breast Cancer Blood-Based Biomarkers Identified
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo